Metagenomi Therapeutics (MGX) Insider & Congress Trades

Smart money at a glance

Filings to Nov 14, 2026

Net buying: insiders sold $5K and bought $23K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: +$18K net
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about MGX filings

Are insiders buying or selling Metagenomi, Inc. Common Stock (MGX) stock?

Net buying: insiders sold $5K and bought $23K of MGX stock on the open market in the 90 days to Nov 14, 2026, according to SEC Form 4 filings. The largest was Reid, Laurence (Director), who bought $23K. The latest filing was on Sep 11, 2026.

Which members of Congress have traded MGX recently?

None. No member of Congress disclosed a MGX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this MGX smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Smart money on MGX

Lean short1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
Lean short1 buy · 2 sales
Form 4 filings, open market.
Congress
No recent politician filings found
Funds
No recent fund filings found
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about MGX filings

Are insiders buying or selling Metagenomi, Inc. Common Stock (MGX) stock?

Which members of Congress have traded MGX recently?

None. No member of Congress disclosed a MGX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this MGX smart-money data?

Insiders

What insiders are doing

7 trades · 6 mo

Bought$23KSold$14K

Buys (1)

RL
Reid Laurence
Dir · Sep 11
$23K
bought

Sells (2)

IJ
Irish Jian
See Remarks · Cluster · Sep 10
$2K
sold
WP
Wapnick Pamela
Chief Financial Officer · Cluster · Sep 10
$2K
sold

2 more trades

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 2 trades

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 10, 2026

Earnings came in 24.3% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 10, 2026

Period ending

Sep 30, 2026

Earnings per share

-$0.56+24.32% beat

-$0.74 expected

Revenue

$2.2M

SEC filing

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 10, 2026	-$0.56est. -$0.74	+24.32%beat	$2.2MSEC filing	-74.8%from $8.7M
Jun 30, 2026Reported Aug 10, 2026	-$0.73est. -$0.63	-15.87%miss	Not on file	Not on file
Mar 31, 2026Reported May 11, 2026	-$0.61est. -$0.55	-10.91%miss	$1.2MSEC filing	-69.8%from $4.1M
Dec 31, 2025Reported Mar 5, 2026	-$0.60est. -$0.58	-2.56%miss	$25.2M · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 11, 2025	-$0.55est. -$0.53	-3.77%miss	$8.7MSEC filing	-24.8%from $11.5M
Jun 30, 2025Reported Aug 12, 2025	-$0.54est. -$0.61	+11.48%beat	$8.5MSEC filing	-57.5%from $20.0M
Mar 31, 2025Reported May 13, 2025	-$0.68est. -$0.51	-33.33%miss	$4.1MSEC filing	-63.0%from $11.2M
Dec 31, 2024Reported Mar 17, 2025	-$0.37est. -$0.77	+51.95%beat	$52.3M · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $0.83
High: $0.83
Low: $0.70
Prev close: $0.76
52-wk high: $1.87
52-wk low: $0.60
Mkt cap: $28.6M
ROE: -60.6%
Beta: 0.83
P/S: 2.1x
P/B: 0.2x
Profit margin: +0.0%
Op margin: -742.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $29M

Valuation

P/S2.11
P/B0.23

Quality

Operating margin-742.0%
ROE-60.6%
ROA-28.2%

Growth

Beta0.83

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

39balanced

20D volatility

68%annualized

52-week range

$0.71

$0.60$1.87

20D support

$0.60recent floor

20D resistance

$0.89recent ceiling

Returns

5D -2.3%20D -15.5%60D -42.4%

Price vs moving averages

SMA20 -8.0%SMA50 -25.7%SMA200 -43.0%

Volume pace

0.95xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 10, 2026

-$0.56est. -$0.74

+24.32%

$2.2MSEC filing

-74.8%from $8.7M

Jun 30, 2026Aug 10, 2026

-$0.73est. -$0.63

-15.87%

Not on file

Mar 31, 2026May 11, 2026

-$0.61est. -$0.55

-10.91%

$1.2MSEC filing

-69.8%from $4.1M

Dec 31, 2025Mar 5, 2026

-$0.60est. -$0.58

-2.56%

$25.2M · FYSEC filing

No year-ago quarter

Sep 30, 2025Nov 11, 2025

-$0.55est. -$0.53

-3.77%

$8.7MSEC filing

-24.8%from $11.5M

Jun 30, 2025Aug 12, 2025

-$0.54est. -$0.61

+11.48%

$8.5MSEC filing

-57.5%from $20.0M

Mar 31, 2025May 13, 2025

-$0.68est. -$0.51

-33.33%

$4.1MSEC filing

-63.0%from $11.2M

Dec 31, 2024Mar 17, 2025

-$0.37est. -$0.77

+51.95%

$52.3M · FYSEC filing

No year-ago quarter

Metagenomi, Inc. Common Stock

Smart money at a glance

What do analysts expect?

Questions about MGX filings

Smart money on MGX

Questions about MGX filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 24.3% above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Metagenomi, Inc. Common Stock

Smart money at a glance

What do analysts expect?

Questions about MGX filings

Smart money on MGX

Questions about MGX filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 24.3% above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Metagenomi, Inc. Common Stock

Overview

Questions about MGX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Metagenomi, Inc. Common Stock

Overview

Questions about MGX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.